Skip to the page

Data / Form D filings / Spark Biomedical Inc.

Spark Biomedical Inc.: Form D filing

Spark Biomedical Inc., a health care company in Dallas, TX, filed a Form D with the SEC in 2023. The latest, on May 12, 2023, reports $16.2 million sold of a $21.8 million offering to 127 investors.

SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.

Company details from the filing

Address
18208 PRESTON ROAD, SUITE D9-531, Dallas, TX, 75252
Phone
(214) 228-2735
Industry
Other Health Care
Entity type
Corporation
Incorporated in
Delaware
Year incorporated
2023
Revenue range
Decline to Disclose
Exemptions claimed
Rule 506(b)
SEC identifier (CIK)
1975271

Form D filings

FiledTypeOfferingSoldRemainingInvestorsFirst saleFiling
May 12, 2023New notice$21,787,050$16,234,159$5,552,891127Mar 7, 2023sec.gov

Executive officers and directors named in the filing

NameRoleNote in the filing
Alejandro R. CovalinExecutive Officer, Director
Navid KhodaparastExecutive Officer, Director
Ted R. CostopoulosDirector
Carl R. DeeleyDirector
Daniel PowellExecutive Officer, Director

Other health care companies in Texas that filed recently

Every Form D from the week of May 8, 2023 · All recent filings in Texas · All recent Other Health Care filings

Read from SEC EDGAR. Amount sold is what Spark Biomedical Inc. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.